AccScience Publishing / AN / Volume 1 / Issue 2 / DOI: 10.36922/an.v1i2.44

Target molecular-based neuroactivity screening of Panax ginseng through network pharmacology integrated molecular docking

Mizna Javed1 Munaza Ijaz2 Manal Buabeid3, 4 Ghulam Murtaza1
Show Less
1 Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan
2 Department of Microbiology, University of Central Punjab, Lahore, Pakistan
3 Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates
4 Medical and Bio Allied Health Sciences Research Centre, Ajman University, Ajman, United Arab Emirates
Advanced Neurology 2022, 1(2), 44
Submitted: 6 March 2022 | Accepted: 23 April 2022 | Published: 25 May 2022
© 2022 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( )

Panax ginseng is a medicinal herb that has therapeutic effects against neuronal damage. The main goal of the present study is to investigate the therapeutic potential of P. ginseng in treating neuronal damage through in silico analysis. The literature review was conducted to create a ingredients-target database for P. ginseng. The database was essential in identifying the targets related to neuronal damage, which was followed by the construction of protein-protein interaction network by the STITCH database. The enrichment analysis was performed using Cytoscape (ClueGO) software. The molecular docking analysis was ran using AutoDock and Discovery Studio. The literature search revealed the presence of 66 compounds in P. ginseng, which subsequently resulted in the retrieval of 102 potential targets of these compounds. They were screened for their association with neuronal damage. Three proteins, namely, Glutathione S-transferase P1, HSP90, and Mitogen-activated protein kinases (MAPK8), were found to be in prime interaction with the relative compounds. Subsequently, 91 Gene ontology terms were found, of which four genes were associated with neuronal damage. Molecular docking analysis also revealed good binding affinities of various compounds of P. ginseng to the selected target, MAPK8. In conclusion, the biological processes linked to the therapeutic action of P. ginseng involve the positive regulation of JUN kinase activity, chaperone-mediated protein folding, and MyD88-dependent toll-like receptor signaling pathway.

Panax ginseng
Biological effects
Neuronal damage
Mechanism of action

Ahuja A, Kim JH, Kim JH, et al., 2018, Functional role of ginseng-derived compounds in cancer. J Ginseng Res, 42(3): 248–254. 


Zhu LY, Jia CH, Park E, 2019, Research on characteristic manifestations of xiaochaihu decoction based on association rules mining. World J Tradit Chin Med, 1: 9–17. 


Das M, Garlick DS, Greiner DL, et al., 2011, The role of JNK in the development of hepatocellular carcinoma. Genes Dev, 25(6): 634–645. 


Wu HX, Hao EW, Du ZC, et al. Research progress on the intervening effects of active components of Chinese herbs on amyloid-beta-induced injury of neural cells. World J Tradit Chin Med, 5: 122–130.


He H, Xu J, Xu Y, et al., 2012, Cardioprotective effects of saponins from Panax japonicus on acute myocardial ischemia against oxidative stress-triggered damage and cardiac cell death in rats. J Ethnopharmacol, 140(1): 73–82.


Hofseth, LJ, Wargovich, MJ, 2007, Inflammation, cancer, and targets of ginseng. J Nutr, 137(Suppl 1): 183S–185S.


Wang C, Chen H, Ma ST, et al., 2021, A network pharmacology approach for exploring the mechanisms of Panax notoginseng saponins in ischaemic stroke. Evid Based Complement Alternat Med, 2021, 5582782. 


Berkenblit, A, Cannistra, SA, 2005, Advances in the management of epithelial neuronal damage. J Reprod Med, 50(6): 426–438. 


Lee, S, Rauch, J, Kolch, W, 2020, Targeting MAPK signaling in cancer: Mechanisms of drug resistance and sensitivity. Int J Mol Sci, 21(3): 1102.


Kurman RJ, Shih IM, 2008, Pathogenesis of neuronal damage: Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol, 27(2): 151–160. 


Liu H, Zhou W, Gao Y, 2019, Discussions on toxic traditional Chinese medicine and new perspectives. World J Tradit Chin Med, 3: 145–150.


Singer, G, Oldt, R, Cohen, Y, et al., 2003, Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst, 95: 484–486. 


Dehari R, Kurman RJ, Logani S, et al., 2007, The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: A morphologic and molecular genetic analysis. Am J Surg Pathol, 31: 1007–1012.


Cakmak H, Guzeloglu-Kayisli O, Kayisli UA, et al., 2009, Immune-endocrine interactions in endometriosis. Front Biosci, 1: 429–443.


Bergqvist A, Bruse C, Carlberg M, et al., 2001, Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium. Fertil Steril, 75(3): 489–495.


Lee CM, Lo HW, Shao RP, et al., 2004, Selective activation of ceruloplasmin promoter in ovarian tumors. Cancer Res, 64(5):1788–1793. 


Gallinelli A, Chiossi G, Giannella L, et al., 2004, Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: Relationships with lymphocyte subsets. Gynecol Endocrinol, 18: 144–151. 


Kim HS, Kim MK, Lee M, et al., 2017, Effect of red Ginseng on genotoxicity and health-related quality of life after adjuvant chemotherapy in patients with epithelial neuronal damage: A randomized, double blind, placebo-controlled trial. Nutrients, 9(7): 772.


Shin HR, Kim JY, Yun TK, et al., 200, The cancer-preventive potential of Panax ginseng: A review of human and experimental evidence. Cancer Causes Control, 11: 565–576. 


Holden F, Amin V, Kuek D, et al., 2019, Taming the fire of nephrotoxic botanicals. World J Tradit Chin Med, 3: 151–163.


Zhang GP, Zhang HJ, Chen TF, et al., 2019, Screening and identifying hepatotoxic components in Polygoni multiflori Radix and Polygoni multiflori Radix Praeparata. World J Tradit Chin Med, 3: 164–170. 


Ru J, Li P, Wang J, et al, 2014, TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J Cheminformatics, 6: 13–19. 


Kuhn M, Szklarczyk D, Pletscher-Frankild S, et al., 2014, STITCH 4: Integration of protein-chemical interactions with user data. Nucleic Acids Res, 42: 401–407.


Bindea G, Mlecnik B, Hackl H, et al., 2009, Cluego: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics, 25: 1091–1093. 


Yao X, Hao H, Li Y, et al., 2011, Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network. BMC Syst. Biol, 5: 79–84. 


Farzaei MH, Rahimi R, Attar F, et al., 2014, Chemical composition, antioxidant and antimicrobial activity of essential oil and extracts of Tragopogon graminifolius, a medicinal herb from Iran. Nat Prod Commun, 9(1): 121–124.


Bae H, Song G, Lim W. Stigmasterol causes neuronal damage cell apoptosis by inducing endoplasmic reticulum and mitochondrial dysfunction. Pharmaceutics, 12(6): 488.


Liao H, Zhu D, Bai M, Chen H, Yan S, Yu J, et al., 2020, Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway. Cancer Cell Int, 20: 480. 


Choi YH, Kong KR, Kim YA, et al., 2003, Induction of Bax and activation of caspases during β-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol, 23(6): 1657–1662. 


Al-Sheddi ES, Al-Oqail MM, El-Shaibany AS, et al., 2015, Phytochemicals and their anti-proliferative activity of Aloe perryi flowers extract against various human cancer cell lines. Plant Med, 81(11): 81-PH2. 


Kim YS, Li XF, Kang KH, et al., 2014, Stigmasterol isolated from marine microalgae Navicula incerta induces apoptosis in human hepatoma HepG2 cells. BMB Rep, 47(8): 433–438.


Awad AB, Williams H, Fink CS, 2001, Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells. Nutr Cancer, 40(2): 157–164. 


Jiang L, Zhao X, Xu J, et al., 2019, The protective effect of dietary phytosterols on cancer risk: A systematic meta-analysis. J Oncol, 2019: 7479518.


Sharmila R, Sindhu G. Modulation of angiogenesis, proliferative response and apoptosis by β-sitosterol in rat model of renal carcinogenesis. Ind J Clin Biochem, 32(2): 142–152. 


Thitilertdecha, P, Tantithavorn, V, Poungpairoj, P, et al., 2019, Determination of suppressive effect on human T-cell activation by hispidulin, nepetin, and vanillic acid. Immunopharmacol Immunotoxicol, 41(6): 591-598.


Mouradian M, Kikawa KD, Johnson ED, et al., 2014, Key roles for GRB2-associated-binding protein 1, phosphatidylinositol- 3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth. Prostaglandins Leukot Essent Fatty Acids, 90(4): 105-115. 


Connolly JM, Coleman M, Rose DP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer, 29(2): 114-119. 


Xu Y, Qian SY. Anti-cancer activities of ω-6 polyunsaturated fatty acids. Biomed J, 37(3): 112-119. 


Shahzad MM, Felder M, Ludwig K, et al., 2018, Trans10, cis12 conjugated linoleic acid inhibits proliferation and migration of neuronal damage cells by inducing ER stress, autophagy, and modulation of Src. PLoS One, 13(1): e0189524. 


Lamb DC, Lei L, Warrilow AG, et al., 2009, The first virally encoded cytochrome p450. J Virol, 83: 8266–8269.


Beedanagari SR, Bebenek I, Bui P, et al., 2009, Resveratrol inhibits dioxin induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicol Sci, 110: 61–67. 


Ghayee HK, Auchus RJ. Basic concepts and recent developments in human steroid hormone biosynthesis. Rev Endocr Metab Disord, 8: 289–300.


Go RE, Hwang KA, Choi KC, 2015, Cytochrome P450 1 family and cancers. J Ster Biochem Mol Biol, 147: 24–30. 


Huang L, Jin Y, Feng S, et al., 2016, Role of Wnt/beta-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca (2+) pathways in cisplatin-induced chemoresistance in Neuronal Damage. Exp Ther Med, 12(6): 3851–3858. 


Wang H, Yamamoto JF, Caberto C, et al., 2010, Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia. Carcinogenesis, 32(2): 203–209.


Wang H, Zhang Z, Han S, et al., CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: A meta-analysis from 19 case-control studies. BMC Cancer, 12: 528. 


Alzahrani AM, Rajendran P. The multifarious link between Cytochrome P450s and cancer. Oxid Med Cell Longev, 2020: 3028387.


Hong CC, Tang BK, Hammond GL, et al., 2004, Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: A cross-sectional study. Breast Cancer Res, 6: R352–R365.


Tian Z, Li YL, Zhao L, et al., 2013, Role of CYP1A2*1F polymorphism in cancer risk: Evidence from a meta-analysis of 46 case-control studies. Gene, 524: 168–174. 


Wang Y, Niu XL, Qu Y, et al., 2010, Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in Neuronal Damage cells. Cancer Lett, 295(1): 110–123. 


Sawers L, Ferguson M, Ihrig B, et al., 2014, Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines. Br J Cancer, 111: 1150–1158.


Dou Y, Jiang X, Xie H, et al., 2019, The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: A molecular aspect. J Ovarian Res, 12: 99. 


Achkar IW, Abdulrahman N, Al-Sulaiti H, et al., 2018, Cisplatin based therapy: The role of the mitogen activated protein kinase signaling pathway. J Transl Med, 16(1): 96. 


Choi KC, Auersperg N, Leung PC, 2003, Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium. Reprod Biol Endocrinol, 7: 71.

Conflict of interest
The authors have no conflict of interest to declare.
Back to top
Advanced Neurology, Electronic ISSN: 2810-9619 Published by AccScience Publishing